Hints and tips:
...Christopher Bowe is the FT’s US healthcare correspondent...
...Schering-Plough’s shares hit a five-year high, as strong sales growth in many products provided further evidence that the company looked increasingly more healthy after four years of rebuilding by Fred Hassan...
...Fred Hassan, Schering-Plough’s chief executive who has been seeking acquisitions since turning his company round, said: “This is not a merger of weakness. This is a merger of strength.”...
...Fred Hassan, chairman and chief executive, took over Schering-Plough in 2003 and was faced with a number of investigations into business practices under his predecessor, Richard Jay Kogan....
...Announcing the improvement in the US drugmaker’s finances, Fred Hassan, chairman and chief executive, said he was now on the lookout for affordable new product acquisitions....
...Fred Hassan, chief executive of Schering-Plough, told the FT in an interview that not only was the company looking externally, but was also changing its internal thinking. to come out swinging after years...
...said Fred Hassan, chief executive. One of Mr Hassan's aims is to stabilise sales in the company's older products, which were showing signs of weakness....
...A better-than-expected first quarter would start to fulfil the promise by Fred Hassan, Schering's chief executive, two years ago that the company would renew earnings growth this year and increase profits...
...This would give Merck two things: 100 per cent of Vytorin's profits and Fred Hassan, Schering-Plough's CEO and a renowned turnround boss....
...Christopher Bowe is the FT’s pharmaceuticals correspondent in the US....
...Barry Jessop, Director of marketing, Pitney Bowes From Geoff Bilbrough Stuart Archibald and others argue that DM is not purely about volume, but really about targeting and relevancy....
...Fred Hassan, chief executive officer of Schering-Plough, the US drugs group, says: "What's urgently needed today is reform in the EU to restore an innovation-friendly environment on the Continent....
International Edition